載入...
Local and Targeted Delivery of Immune Checkpoint Blockade Therapeutics
Immune checkpoint blockade (ICB) therapy elicits antitumor response by inhibiting immune suppressor components, including programmed cell death protein 1 and its ligand (PD-1/PD-L1) and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4). Despite improved therapeutic efficacy, the clinical response...
Na minha lista:
| 發表在: | Acc Chem Res |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8177058/ https://ncbi.nlm.nih.gov/pubmed/33073988 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.accounts.0c00339 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|